HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

New L'Oreal Consumer, Luxury Entries Fuel “Encouraging” Q1 Gains

This article was originally published in The Rose Sheet

  • News

Executive Summary

L'Oreal attributes a strong first quarter to new product innovations, especially in its consumer and luxury divisions, as well as the continued rebound of its U.S. business, Chairman and CEO Jean-Paul Agon said during an April 19 analyst call.

You may also be interested in...



CEW Awards Most Innovative Products in Beauty

The Cosmetic Executive Women celebrated some of the most innovative products in beauty at its 17th annual awards ceremony, known as the Beauty “Oscars,” for its star-studded appeal.

CEW Awards Most Innovative Products in Beauty

The Cosmetic Executive Women celebrated some of the most innovative products in beauty at its 17th annual awards ceremony, known as the Beauty “Oscars,” for its star-studded appeal.

In Brief

Dr. Bronner’s Expands To Grocery Aisle

Table

View full table

Tags:
Latest Headlines

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

See All
UsernamePublicRestriction

Register

RS017540

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By